In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I.
about
Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a reviewSource and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.Efficacy of tomato concentrates in mouse models of dyslipidemia and cancer.Recent Advances in Targeted, Self-Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis.Targeting and therapeutic peptides in nanomedicine for atherosclerosis.Dynamic Aspects of Macrophage Polarization during Atherosclerosis Progression and Regression.High-density lipoprotein mimetics: promises and challenges.Investigational therapies for hypercholesterolemia.The potential of apolipoprotein mimetic peptides in the treatment of atherosclerosisSelf-Assembling Cyclic d,l-α-Peptides as Modulators of Plasma HDL Function. A Supramolecular Approach toward Antiatherosclerotic Agents.Mimetic peptides of human apoA-I helix 10 get together to lower lipids and ameliorate atherosclerosis: is the action in the gut?Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled Trial.Recent Advances in Managing Atherosclerosis via Nanomedicine.Peptide Mimetics: Fast-Forward Look.Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer.
P2860
Q34238630-A0C07941-4ED9-4336-93CF-98A38BC5311DQ35217048-2B27E1F2-9D65-471B-BD9F-AF0EEAD24F97Q35822272-1383C747-FE59-4975-B608-0CD8D0561C9DQ36598388-ABD02B8B-2F26-41D4-BC69-A26283C5ED4AQ36913594-56993E63-993D-4B0F-AEBF-CC401B5878A2Q38271958-F811C3B1-3687-43EB-A0FD-6179CE7AFDBDQ38650575-63F8E852-1C55-4EFE-B968-D4FDD33658AEQ39215123-6777C7D1-6470-4103-A172-394FAEBFE088Q40492051-86AE258A-BCE9-4736-8DFA-8F04592C629AQ40993177-4D22274B-B856-4D4A-A711-23F460F946E1Q42913663-FC3ACF5A-95D9-42F7-9A28-759A50B48E97Q46350113-DF047C71-F334-459D-A13B-86953A2F2D1AQ47251361-4573B7D5-D817-4A40-AF6C-8A8DD23AA368Q53813992-7584C9F9-E828-4D9D-83FA-1DE567B307F1Q55222132-E58748B1-92F2-49CF-BD15-CFF0A0BF9FDE
P2860
In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@ast
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@en
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@nl
type
label
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@ast
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@en
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@nl
prefLabel
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@ast
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@en
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@nl
P2093
P2860
P356
P1476
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@en
P2093
Audrey S Black
Bruce E Maryanoff
David J Bonnet
Linda K Curtiss
M Reza Ghadiri
Yannan Zhao
P2860
P304
P356
10.1194/JLR.M049262
P50
P577
2014-06-29T00:00:00Z